DJIA 15,307.17 -80.41 -0.52%
NASDAQ 3,463.30 -38.82 -1.11%
S&P 500 1,655.35 -13.81 -0.83%

3.02 -0.09 (-2.89%)

REAL-TIME: Last trade at

Extended Hours: $3.02 $0.00 (0.00%)
Quote as of (NASDAQ)


company name or ticker

Recent Quotes

TSPT $3.02 -2.89%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.14
Previous Close $3.11
Daily Range $2.87 - $3.14
52-Week Range $2.87 - $7.45
Market Cap $56.6M
P/E Ratio -3.49
Dividend (Yield) $0.00 (0.0%)
Volume 226,005
Average Daily Volume 156,938
Current FY EPS -$1.06

Sector

Healthcare

Industry

Drugs

Transcept Pharmaceuticals (TSPT) Description

Transcept Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. Website: http://www.transcept.com/

News & Commentary Rss Feed

4 Biotechs' Dominant Moves

A closer look at today's big market movers

SmithOnStocks Opines On Stocks: May 19th Edition

Cheerleaders: Look Beyond Pharma For Jobs

Benzinga's Top Downgrades

Transcept Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript

Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog

Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog

Impax Beats Earnings Estimate - Analyst Blog

AMAG Narrows Loss; Maintains View - Analyst Blog

Merck - BMY in HCV Deal - Analyst Blog

Merck - BMY in HCV Deal - Analyst Blog

Merck In-Licenses from Xenon - Analyst Blog

Merck In-Licenses from Xenon - Analyst Blog

Sanofi's Vaccine Gets EU Approval - Analyst Blog

See More TSPT News...

TSPT's Top Competitors

TSPT $3.02 (-2.89%)
Current stock: TSPT
AMGN $104.53 (0.28%)
Current stock: AMGN
GILD $55.93 (-0.96%)
Current stock: GILD
BIIB $233.07 (0.75%)
Current stock: BIIB